tiprankstipranks
Trending News
More News >
Hansa Biopharma (SE:HNSA)
:HNSA
Sweden Market

Hansa Biopharma AB (HNSA) Financial Statements

Compare
0 Followers

Hansa Biopharma AB Financial Overview

Hansa Biopharma AB's market cap is currently kr1.47B. The company's EPS TTM is kr-13.06; its P/E ratio is ―; Hansa Biopharma AB is scheduled to report earnings on ―, and the estimated EPS forecast is kr-2.61. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 171.32Mkr 134.09Mkr 154.53Mkr 33.88Mkr 6.10M
Gross Profitkr 87.76Mkr 70.95Mkr 116.05Mkr 18.45Mkr 5.10M
Operating Incomekr -634.34Mkr -788.50Mkr -576.12Mkr -539.58Mkr -425.08M
EBITDAkr -616.54Mkr -714.55Mkr -554.26Mkr -538.83Mkr -413.08M
Net Incomekr -806.74Mkr -831.72Mkr -611.13Mkr -548.28Mkr -420.85M
Balance Sheet
Cash & Short-Term Investmentskr 405.28Mkr 732.06Mkr 1.50Bkr 888.96Mkr 1.38B
Total Assetskr 800.64Mkr 1.02Bkr 1.69Bkr 1.01Bkr 1.43B
Total Debtkr 1.08Bkr 866.77Mkr 791.09Mkr 35.38Mkr 5.04M
Net Debtkr 673.73Mkr 134.71Mkr -705.09Mkr -615.96Mkr -1.13B
Total Liabilitieskr 1.39Bkr 1.19Bkr 1.08Bkr 255.24Mkr 192.37M
Stockholders' Equitykr -589.32Mkr -167.88Mkr 602.91Mkr 757.57Mkr 1.24B
Cash Flow
Free Cash Flowkr -734.04Mkr -755.94Mkr -506.06Mkr -483.57Mkr -290.57M
Operating Cash Flowkr -733.92Mkr -755.65Mkr -502.73Mkr -481.17Mkr -290.27M
Investing Cash Flowkr -116.00Kkr -284.00Kkr 229.31Mkr -2.40Mkr 182.53M
Financing Cash Flowkr 405.84Mkr -7.54Mkr 1.12Bkr -4.86Mkr 1.07B
Currency in SEK

Hansa Biopharma AB Earnings and Revenue History

Hansa Biopharma AB Debt to Assets

Hansa Biopharma AB Cash Flow

Hansa Biopharma AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis